|
(2,2,3,4,4-d5)-zymosterol
|
K029094-1mg
|
99% |
1246298-29-2 |
1mg
|
¥ 10117.0
|
4~8周 |
0 |
科威 |
|
sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1’-[2’,3’-dioleoyl]-glycerol (ammonium salt)
|
K029093-5mg
|
99% |
1246298-28-1 |
5mg
|
¥ 4190.0
|
4~8周 |
0 |
科威 |
|
sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1’-[2’,3’-dioleoyl]-glycerol (ammonium salt)
|
K029093-50mg
|
99% |
1246298-28-1 |
50mg
|
¥ 23508.0
|
4~8周 |
0 |
科威 |
|
sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1’-[2’,3’-dioleoyl]-glycerol (ammonium salt)
|
K029093-25mg
|
99% |
1246298-28-1 |
25mg
|
¥ 13286.0
|
4~8周 |
0 |
科威 |
|
sn-[2,3-dioleoyl]-glycerol-1-phospho-sn-1’-[2’,3’-dioleoyl]-glycerol (ammonium salt)
|
K029093-10mg
|
99% |
1246298-28-1 |
10mg
|
¥ 6337.0
|
4~8周 |
0 |
科威 |
|
1-stearoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt)
|
K029092-10mg
|
99% |
1246298-16-7 |
10mg
|
¥ 18398.0
|
4~8周 |
0 |
科威 |
|
1-stearoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt)
|
K029092-5mg
|
99% |
1246298-16-7 |
5mg
|
¥ 10117.0
|
4~8周 |
0 |
科威 |
|
1-stearoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt)
|
K029092-1mg
|
99% |
1246298-16-7 |
1mg
|
¥ 2555.0
|
4~8周 |
0 |
科威 |
|
1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1''-myo-inositol) (ammonium salt)
|
K029091-500ug
|
99% |
1246298-13-4 |
500ug
|
¥ 7664.0
|
4~8周 |
0 |
科威 |
|
1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1''-myo-inositol) (ammonium salt)
|
K029091-1mg
|
99% |
1246298-13-4 |
1mg
|
¥ 13696.0
|
4~8周 |
0 |
科威 |
|
1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1''-myo-inositol) (ammonium salt)
|
K029091-100ug
|
99% |
1246298-13-4 |
100ug
|
¥ 1920.0
|
4~8周 |
0 |
科威 |
|
VU 0364439
|
K029090-10mg
|
99% |
1246086-78-1 |
10mg
|
¥ 2440.0
|
4~8周 |
0 |
科威 |
|
VU 0364439
|
K029090-50mg
|
99% |
1246086-78-1 |
50mg
|
¥ 7799.0
|
4~8周 |
0 |
科威 |
|
氨基磺酸鎳
|
K001223-2.5kg
|
99%(高純?cè)噭? |
124594-15-6 |
2.5kg
|
¥ 410.0
|
現(xiàn)貨 |
0 |
科威 |
|
氨基磺酸鎳
|
K001223-500g
|
99%(高純?cè)噭? |
124594-15-6 |
500g
|
¥ 116.0
|
現(xiàn)貨 |
0 |
科威 |
|
氨基磺酸鎳
|
K001223-100g
|
99%(高純?cè)噭? |
124594-15-6 |
100g
|
¥ 56.0
|
現(xiàn)貨 |
0 |
科威 |
|
BGT226 (NVP-BGT226)
|
K029089-5mg
|
99% |
1245537-68-1 |
5mg
|
¥ 4480.0
|
4~8周 |
0 |
科威 |
|
BGT226 (NVP-BGT226)
|
K029089-50mg
|
99% |
1245537-68-1 |
50mg
|
¥ 17756.0
|
4~8周 |
0 |
科威 |
|
BGT226 (NVP-BGT226)
|
K029089-10mg
|
99% |
1245537-68-1 |
10mg
|
¥ 6139.0
|
4~8周 |
0 |
科威 |
|
PBFI, AM
|
K029088-1mg
|
98%(熒光分析試劑) |
124549-23-1 |
1mg
|
¥ 5501.0
|
4~8周 |
0 |
科威 |
|
4-(5-amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-p-tolylpiperazine-1-carboxamide
|
K029086-5mg
|
99% |
1245319-54-3 |
5mg
|
¥ 7500.0
|
4~8周 |
0 |
科威 |
|
4-(5-amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-p-tolylpiperazine-1-carboxamide
|
K029086-10mg
|
99% |
1245319-54-3 |
10mg
|
¥ 13499.0
|
4~8周 |
0 |
科威 |
|
2,2'-二喹啉-4,4'-二羧酸
|
K004261-5g
|
90% |
1245-13-2 |
5g
|
¥ 298.0
|
現(xiàn)貨 |
0 |
科威 |
|
2,2'-二喹啉-4,4'-二羧酸
|
K004261-1g
|
90% |
1245-13-2 |
1g
|
¥ 89.0
|
現(xiàn)貨 |
0 |
科威 |